John Browne has joined Apax Partners as non-executive chairman of its advisory board. Browne announced last week that he would step down as CEO of BP PLC in July. www.apax.com
Marios Fotiadis has joined Enterprise Partners Venture Capital as a managing director focused on opportunities in the life sciences spaced. He previously was a venture partner with Advent International and, before that, was CEO of Achillion Pharmaceuticals. www.epvc.com
Saul Klein has joined Index Ventures as a London-based partner, according to Financial News Online. He is a former Skype executive who previously co-founded Video Island.
Fenway Partners has promoted Aron Schwartz to managing director. He joined the firm in 1999. www.fenwaypartners.com
Richard Steinman has joined Greenhill & Co. as a managing director focused on advisory opportunities in the retail sector. He previously led the global retail group at Morgan Stanley. www.greenhill-co.com
RingCentral Inc., a San Mateo, Calif.-based provider of enterprise telecom services, has secured $6.25 million of a $12.89 million Series A round, according to a regulatory filing. Backers include Khosla Ventures and Sequoia Capital. The company was founded in 1991, and was owned by Motorola between 1998 and 1999. www.ringcentral.com
Dinan & Co. has promoted Tom Main and Jeremy Wallace from senior associate to partner. Both have been with the firm for the past ten years. www.dealassist.com
Music Nation, a New York-based artist development company that is launching an online video music competition, has raised $5.5 million in Series A funding. Greylock Partners led the deal, and was joined by Point Judith Capital. www.musicnation.com
Waud Capital Partners has promoted David Neighbours to the position of vice president. He joined the firm in 2003 as an associate, and was later promoted to senior associate. His current board seats include Hospitalists Management Group, Regency Hospital Company and True Partners Consulting. www.waudcapital.com
Ovalis Inc., a Mountain View, Calif.-based developer of catheter-based products for repairing cardiac defects, has raised around $6.6 million in Series B funding, according to a regulatory filing. Return backers include Abbott Labs, De Novo Ventures and Latterell Venture Partners.